Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2007 049 702.7 |
| 96 | EP file number | EAKZ | 11 18 6203.3 |
| 97 | EP publication number | EPN | 2410054 |
| 54 | Designation/title | TI | ANTISENSE-VERBINDUNGEN |
| 51 | IPC main class | ICM
(ICMV) | C12N 15/113 (2010.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/712 (2006.01) |
| 22 | DE application date | DAT | Oct 18, 2007 |
| 96 | EP application date | EAT | Oct 18, 2007 |
| 43 | Date of first publication | OT | Jan 25, 2012 |
| Date of publication of grant | PET | Jan 25, 2017 |
| 71/73 | Applicant/owner | INH | Ionis Pharmaceuticals, Inc., Carlsbad, Calif., US |
| 72 | Inventor | IN | Swayze, Eric E., Carlsbad, CA 92009, US |
| 74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
852894 P
Oct 18, 2006
|
| Due date | FT
FG | Oct 31, 2025
Annual fee for the 19th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002410054
Searchable text:
EP000002410054
Original document:
EP000002410054B1
Searchable text:
EP000002410054B1
Original document:
EP000002410054B2
Searchable text:
EP000002410054B2 |
| 43 | Date of first publication | EVT | Jan 25, 2012 |
| Date of the first transfer into DPMAregister | EREGT | Mar 9, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 11, 2024
(Show all update days)(Hide all update days)- Sep 11, 2024
- Mar 9, 2012
- Date of the first transfer into DPMAregister
|
